Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoires Sarget was a prominent French pharmaceutical company headquartered in Mérignac, specializing in the development and production of over-the-counter (OTC) and prescription medications. The company was widely recognized for its flagship product Sargenor, an anti-fatigue treatment based on arginine aspartate, as well as digestive health products like Hépatoum. In 1995, Laboratoires Sarget was acquired by the Swedish pharmaceutical group Astra, which later merged with Zeneca to form AstraZeneca. The acquisition allowed Astra to strengthen its presence in the French market and utilize Sarget's manufacturing capabilities. Following the merger, many of Sarget's legacy brands were eventually divested to other companies such as Meda (now Viatris), and its primary manufacturing site was sold to the CDMO Fareva in 2005.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoires Sarget.